Xuexia Zhang - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Xuexia Zhang

Showing results (51-60 of 53) with videos related to

Pageof 6

Sort By:

You have reached the last page of results.This site can display upto 53 results.

European Journal of Pharmacology|September 7, 2016

Discovery of a new structural class of competitive hDHODH inhibitors with in vitro and in vivo anti-inflammatory, immunosuppressive effectsWenbin Shen, Xiao Ren, Jingtong Zhu, et al.

RSC Advances|April 15, 2022

New protein tyrosine phosphatase inhibitors from fungus <i>Aspergillus gorakhpurensis</i> F07ZB1707Yannan Ji, Qiqi Zhou, Guosheng Liu, et al.

Molecular Pharmacology|July 26, 2017

Altenusin, a Nonsteroidal Microbial Metabolite, Attenuates Nonalcoholic Fatty Liver Disease by Activating the Farnesoid X ReceptorZhihui Zheng, Zanmei Zhao, Shuqiang Li, et al.

Pageof 6

Search research articles

Showing results (51-60 of 53) with videos related to

Sort By:

Pageof 6

You have reached the last page of results.This site can display upto 53 results.

European Journal of Pharmacology|September 7, 2016

Discovery of a new structural class of competitive hDHODH inhibitors with in vitro and in vivo anti-inflammatory, immunosuppressive effectsWenbin Shen, Xiao Ren, Jingtong Zhu, et al.

RSC Advances|April 15, 2022

New protein tyrosine phosphatase inhibitors from fungus <i>Aspergillus gorakhpurensis</i> F07ZB1707Yannan Ji, Qiqi Zhou, Guosheng Liu, et al.

Molecular Pharmacology|July 26, 2017

Altenusin, a Nonsteroidal Microbial Metabolite, Attenuates Nonalcoholic Fatty Liver Disease by Activating the Farnesoid X ReceptorZhihui Zheng, Zanmei Zhao, Shuqiang Li, et al.

Pageof 6